0.55 TRY
454.58 M TRY
8.15 B TRY
67.58 M
About GEN ILAC
Sector
Headquarters
Ankara
Founded
1998
Website
ISIN
TREGENL00024
FIGI
BBG011QRRP85
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. It offers drugs against endocrinology, neurology, onco-haematology , nephrology, and metabolism disorders. Its products include Cajex, Contra-K, Epamor, Ferint, Genium, Genkort, Intrafen, Ilopera, Novils, Parigen, Pleksor, and Vorigen. The company was founded in 1998 and is headquartered in Ankara, Turkey.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GENIL is 89.95 TRY — it has increased by 2.22% in the past 24 hours. Watch GEN ILAC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange GEN ILAC stocks are traded under the ticker GENIL.
GENIL stock has risen by 9.03% compared to the previous week, the month change is a 4.35% rise, over the last year GEN ILAC has showed a 56.03% increase.
GENIL reached its all-time high on Sep 25, 2024 with the price of 95.00 TRY, and its all-time low was 11.80 TRY and was reached on Aug 5, 2021. View more price dynamics on GENIL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GENIL stock is 2.86% volatile and has beta coefficient of 0.51. Track GEN ILAC stock price on the chart and check out the list of the most volatile stocks — is GEN ILAC there?
Today GEN ILAC has the market capitalization of 26.98 B, it has decreased by −1.95% over the last week.
Yes, you can track GEN ILAC financials in yearly and quarterly reports right on TradingView.
GENIL net income for the last quarter is −181.46 M TRY, while the quarter before that showed 161.69 M TRY of net income which accounts for −212.23% change. Track more GEN ILAC financial stats to get the full picture.
GEN ILAC dividend yield was 2.37% in 2023, and payout ratio reached 73.33%. The year before the numbers were 2.15% and 30.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 622.00 employees. See our rating of the largest employees — is GEN ILAC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GEN ILAC EBITDA is 1.21 B TRY, and current EBITDA margin is 10.61%. See more stats in GEN ILAC financial statements.
Like other stocks, GENIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GEN ILAC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GEN ILAC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GEN ILAC stock shows the buy signal. See more of GEN ILAC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.